Prognostic model for unresectable hepatocellular carcinoma treated with transarterial therapy plus TKIs and anti-PD-1 antibodies
Tong Yuan(University of Oklahoma), Zhiyong Huang(Beijing Institute of Technology), Jun-Jie Liu(North China University of Science and Technology), Xue Lin(Dalian Medical University), Guang Tan(Tongji Hospital), Pengbo Zhang(Tongji Hospital), Yi Zhou(Tongji Hospital), Ronghua Zhu(Tongji Hospital), Chunyu Zhang(Tongji Hospital), Xing Lv(Air Force Medical University)
Cited by 0
Related Papers
Climate warming leads to divergent succession of grassland microbial communities
|Nature Climate Change|2018|378
Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques
|Nature Biotechnology|2011|321
Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE-/- mice fed with HFD
|Journal of Ethnopharmacology|2020|87
Leveraging Aptamer-Based DNA Nanotechnology for Bioanalysis and Cancer Therapeutics
|Accounts of Materials Research|2024|87